Navigation Links
Statement on Comparative Effectiveness Research Under Senate Appropriations Committee Stimulus Bill
Date:1/27/2009

Language a Step Forward for Patient-Provider Decision Making

Further Action Needed to Ensure Research Reflects America

WASHINGTON, Jan. 27 /PRNewswire-USNewswire/ -- "The Senate today improved on a comparative effectiveness research (CER) package from the House by focusing the $1.1 billion dollar research effort on clinical effectiveness," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group. She added, "The Senate Appropriations Committee has rejected House report language that put cost over quality and was a prescription for bad health.

"House stimulus package language had urged that those treatments found 'more expensive, will no longer be prescribed.' The Senate instead calls for the CER program to focus specifically on clinical effectiveness. The Senate language recognizes that a decision on the best treatment for an individual patient must be made between the patient and their provider, not a federal research or rulemaking body.

"While the Senate language is an improvement , it is important that further steps be taken to ensure that research and governance reflect those that the research seeks to serve."

According to Dr. Delgado two outstanding issues are critical.

1. Final legislation must specifically enforce current policies for inclusion in research. House language was silent on inclusion of gender, race, ethnicity, and disability. While the Senate improves on House language, the final legislation should specifically call for research to be in compliance with the federal Agency for Healthcare Research and Quality Policy on the Inclusion of Priority Populations in Research.

2. Governance must be changed from an all federal board to include majority governance by patient and provider groups. Current House language calls for a 15 person governance board of only federal officials to oversee the $1.1 billion CER program. An all federal panel will not reflect the real-life concerns of patients and providers and inevitably lead to science and spending that does not meet the needs of patients for better quality care.

"We appreciate the work of the Senate Appropriations and Finance Committees and in particular thank Senators Baucus, Conrad, Harkin, and Inouye for their leadership on improving the CER program under the stimulus package. We look forward to our work with the Senate and House in the days ahead to develop a package that puts patients and quality first."

About the National Alliance for Hispanic Health

The National Alliance for Hispanic Health is the nation's foremost source of information and trusted advocate for the health of Hispanics in the United States. The Alliance represents thousands of Hispanic health providers across the nation providing services to more than 15 million each year, making a daily difference in the lives of Hispanic communities and families. For more information, visit http://www.hispanichealth.org or call the Alliance's Su Familia National Hispanic Family Health Helpline at 1-866-783-2645.


'/>"/>
SOURCE National Alliance for Hispanic Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Psychoanalysts Approve Position Statement on Homosexuals and Bisexuals Serving in the Military
2. American Life League Statement on Pelosis State-Enforced War on Preborn Babies
3. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
4. Endocare Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With Galil Medical
5. Pelosi Statement on Obama Executive Order Repealing Global Gag Rule
6. Catholics for Choice Statement on Overturning the Mexico City Policy
7. UHW Statement on Ray Marshall Trusteeship Recommendations
8. Pelosi Statement on the 36th Anniversary of Roe v. Wade
9. Statement by UHW on SEIUs Claims Regarding SEIU-Trusteeship Hearing Process Chaired by Ray Marshall
10. Capital Blue Cross Issues Statement on Withdrawal of Merger
11. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... concerning this present generation. Yisrayl makes an astounding statement when he says that ... explains that the Bible details the current times so plainly that anyone should be ...
(Date:2/24/2017)... ... 2017 , ... Congratulations to Head Over Heels’ elite gymnast ... Ms. Esparza qualified into this prestigious status after winning the Vault, Floor, ... Nevada. Frida is one of approximately 25 gymnasts in the nation who earns ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Dry eye market? ...
(Date:2/24/2017)... Juan Monteverde , founder and managing ... boutique securities firm headquartered at the Empire State Building ... that a class action lawsuit has been filed in the ... Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or the "Company") on ... 2015 and December 30, 2016, inclusive (the "Class Period").  ...
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une ... d,annoncer les excellents résultats semestriels clos le 31 décembre ... présentation complète « Résultats et mise à jour sur la ... Faits marquants ... $ ; en hausse de 104 %) Bénéfice ...
Breaking Medicine Technology: